(VIANEWS) - CyberOptics Corporation (CYBE), Organogenesis Holdings (ORGO), Edwards Lifesciences (EW) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. CyberOptics Corporation (CYBE)
28.3% sales growth and 15.58% return on equity
CyberOptics Corporation designs, develops, and manufactures high precision sensing technology solutions and system products for inspection and metrology worldwide.
CyberOptics Corporation's sales growth this year is expected to be 30.6% and 10.7% for next year.
Year-on-year quarterly revenue growth grew by 33.3%, now sitting on 87.57M for the twelve trailing months.
Volume
Today's last reported volume for CyberOptics Corporation is 26490 which is 33.71% below its average volume of 39966.
CyberOptics Corporation's sales growth for the next quarter is 28.3%. The company's growth estimates for the present quarter and the next is 20% and 47.4%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 15.58%.
Volatility
CyberOptics Corporation's last day, last week, and last month's current intraday variation average was 1.58%, 3.78%, and 2.54%, respectively.
CyberOptics Corporation's highest amplitude of average volatility was 3.70% (day), 6.01% (last week), and 5.20% (last month), respectively.
CyberOptics Corporation's Stock Yearly Top and Bottom Value
CyberOptics Corporation's stock is valued at $41.45 at 05:22 EST, way under its 52-week high of $49.10 and way above its 52-week low of $20.81.
CyberOptics Corporation's Moving Average
CyberOptics Corporation's value is under its 50-day moving average of $42.19 and way above its 200-day moving average of $36.54.2. Organogenesis Holdings (ORGO)
19.7% sales growth and 48.88% return on equity
Organogenesis Holdings Inc., a regenerative medicine company, develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States.
Organogenesis Holdings 's sales growth this year is anticipated to be 37.1% and 9.6% for next year.
Year-on-year quarterly revenue growth grew by 12.9%, now sitting on 446.31M for the twelve trailing months.
Volume
Today's last reported volume for Organogenesis Holdings is 503110 which is 53.13% below its average volume of 1073510.
Organogenesis Holdings 's sales growth for the next quarter is 19.7%. The company's growth estimates for the ongoing quarter and the next is a negative 46.7% and 14.3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 48.88%.
Volatility
Organogenesis Holdings 's last day, last week, and last month's current intraday variation average was 2.17%, 3.27%, and 2.65%, respectively.
Organogenesis Holdings 's highest amplitude of average volatility was 6.67% (day), 6.21% (last week), and 5.65% (last month), respectively.
Organogenesis Holdings 's Stock Yearly Top and Bottom Value
Organogenesis Holdings 's stock is valued at $9.27 at 05:22 EST, way below its 52-week high of $24.34 and way above its 52-week low of $6.64.
Organogenesis Holdings 's Moving Average
Organogenesis Holdings 's worth is way under its 50-day moving average of $10.40 and way under its 200-day moving average of $15.27.3. Edwards Lifesciences (EW)
18.2% sales growth and 32.6% return on equity
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States and internationally.
Edwards Lifesciences's sales growth this year is anticipated to be 21.4% and 11.1% for next year.
Year-on-year quarterly revenue growth grew by 48.8%, now sitting on 4.93B for the twelve trailing months.
Volume
Today's last reported volume for Edwards Lifesciences is 679994 which is 70.84% below its average volume of 2332640.
Edwards Lifesciences's sales growth for the next quarter is 18.2%. The company's growth estimates for the current quarter and the next is 5.9% and 12%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 32.6%.
Volatility
Edwards Lifesciences's last day, last week, and last month's current intraday variation average was 0.94%, 0.73%, and 1.33%, respectively.
Edwards Lifesciences's highest amplitude of average volatility was 2.44% (day), 1.70% (last week), and 2.13% (last month), respectively.
Edwards Lifesciences's Stock Yearly Top and Bottom Value
Edwards Lifesciences's stock is valued at $128.25 at 05:22 EST, above its 52-week high of $123.27.
Edwards Lifesciences's Moving Average
Edwards Lifesciences's worth is way higher than its 50-day moving average of $114.72 and way above its 200-day moving average of $108.17.4. Watsco (WSO)
15.1% sales growth and 22.95% return on equity
Watsco, Inc., together with its subsidiaries, distributes air conditioning, heating, and refrigeration equipment; and related parts and supplies in the United States, Canada, Mexico, and Puerto Rico.
Watsco's sales growth this year is anticipated to be 20.9% and 3.7% for next year.
Year-on-year quarterly revenue growth grew by 36.5%, now sitting on 5.68B for the twelve trailing months.
Volume
Today's last reported volume for Watsco is 326077 which is 168.55% above its average volume of 121421.
Watsco's sales growth for the next quarter is 15.1%. The company's growth estimates for the ongoing quarter and the next is 23.2% and 37.7%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 22.95%.
Volatility
Watsco's last day, last week, and last month's current intraday variation average was 2.92%, 1.78%, and 1.41%, respectively.
Watsco's highest amplitude of average volatility was 3.29% (day), 2.92% (last week), and 2.33% (last month), respectively.
Watsco's Stock Yearly Top and Bottom Value
Watsco's stock is valued at $304.81 at 05:22 EST, below its 52-week high of $318.98 and way higher than its 52-week low of $223.36.
Watsco's Moving Average
Watsco's worth is above its 50-day moving average of $297.07 and higher than its 200-day moving average of $283.69.5. Innospec (IOSP)
10% sales growth and 9.57% return on equity
Innospec Inc. develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally.
Innospec's sales growth this year is anticipated to be 21.3% and 8.5% for next year.
Year-on-year quarterly revenue growth grew by 41.9%, now sitting on 1.38B for the twelve trailing months.
Volume
Today's last reported volume for Innospec is 82889 which is 36.2% below its average volume of 129930.
Innospec's sales growth for the next quarter is 10%. The company's growth estimates for the present quarter and the next is a negative 18.1% and 8.5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 9.57%.
Volatility
Innospec's last day, last week, and last month's current intraday variation average was 3.13%, 2.34%, and 1.78%, respectively.
Innospec's highest amplitude of average volatility was 2.48% (day), 3.82% (last week), and 3.24% (last month), respectively.
Innospec's Stock Yearly Top and Bottom Value
Innospec's stock is valued at $88.74 at 05:22 EST, way below its 52-week high of $107.73 and above its 52-week low of $81.00.
Innospec's Moving Average
Innospec's worth is above its 50-day moving average of $88.32 and under its 200-day moving average of $93.13.6. First Midwest Bancorp (FMBI)
9.1% sales growth and 6.17% return on equity
First Midwest Bancorp, Inc. operates as the bank holding company for First Midwest Bank that provides various banking products and services.
First Midwest Bancorp's sales growth this year is anticipated to be 5.5% and a negative 1% for next year.
Year-on-year quarterly revenue growth grew by 30.9%, now sitting on 704.08M for the twelve trailing months.
Volume
Today's last reported volume for First Midwest Bancorp is 615245 which is 17.94% above its average volume of 521659.
First Midwest Bancorp's sales growth for the next quarter is 9.1%. The company's growth estimates for the present quarter and the next is 27.3% and 2.3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 6.17%.
Volatility
First Midwest Bancorp's last day, last week, and last month's current intraday variation average was 0.21%, 1.75%, and 1.61%, respectively.
First Midwest Bancorp's highest amplitude of average volatility was 2.29% (day), 3.33% (last week), and 2.85% (last month), respectively.
First Midwest Bancorp's Stock Yearly Top and Bottom Value
First Midwest Bancorp's stock is valued at $19.51 at 05:22 EST, way under its 52-week high of $24.28 and way higher than its 52-week low of $15.05.
First Midwest Bancorp's Moving Average
First Midwest Bancorp's value is under its 50-day moving average of $20.05 and under its 200-day moving average of $20.06.7. Shutterstock (SSTK)
6.9% sales growth and 23.32% return on equity
Shutterstock, Inc., a technology company, provides content, and tools and services in North America, Europe, and internationally.
Shutterstock's sales growth this year is anticipated to be 12.9% and 8.4% for next year.
Year-on-year quarterly revenue growth grew by 17.7%, now sitting on 748.58M for the twelve trailing months.
Volume
Today's last reported volume for Shutterstock is 24475 which is 88.85% below its average volume of 219593.
Shutterstock's sales growth is a negative 0% for the current quarter and 6.9% for the next. The company's growth estimates for the ongoing quarter and the next is a negative 27.5% and negative -44.1%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 23.32%.
Volatility
Shutterstock's last day, last week, and last month's current intraday variation average was 1.43%, 1.25%, and 2.12%, respectively.
Shutterstock's highest amplitude of average volatility was 2.06% (day), 2.36% (last week), and 3.59% (last month), respectively.
Shutterstock's Stock Yearly Top and Bottom Value
Shutterstock's stock is valued at $111.68 at 05:22 EST, way under its 52-week high of $128.36 and way higher than its 52-week low of $62.21.
Shutterstock's Moving Average
Shutterstock's worth is under its 50-day moving average of $115.61 and higher than its 200-day moving average of $104.58.8. Edison International (EIX)
5.1% sales growth and 4.83% return on equity
Edison International, through its subsidiaries, engages in the generation, transmission, and distribution of electricity in the United States.
Edison International's sales growth this year is anticipated to be 5.5% and 3.4% for next year.
Year-on-year quarterly revenue growth grew by 11%, now sitting on 14.08B for the twelve trailing months.
Volume
Today's last reported volume for Edison International is 264665 which is 87.15% below its average volume of 2061130.
Edison International's sales growth is a negative 0% for the present quarter and 5.1% for the next. The company's growth estimates for the present quarter and the next is 5.4% and negative -12.6%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 4.83%.
Volatility
Edison International's last day, last week, and last month's current intraday variation average was 1.10%, 1.03%, and 0.68%, respectively.
Edison International's highest amplitude of average volatility was 2.69% (day), 2.21% (last week), and 1.43% (last month), respectively.
Edison International's Stock Yearly Top and Bottom Value
Edison International's stock is valued at $67.77 at 05:22 EST, below its 52-week high of $68.37 and way higher than its 52-week low of $53.92.